cyclic-gmp has been researched along with eprosartan* in 1 studies
1 other study(ies) available for cyclic-gmp and eprosartan
Article | Year |
---|---|
Angiotensin II signaling activities the NO-cGMP pathway in rat proximal tubules.
We examined the signal transduction cascade of angiotensin II in isolated rat proximal tubules. Angiotensin II induced a rapid (15 sec) concentration-dependent rise in intracellular free Ca2+ (EC50 = 1.7 nM). The rise in Ca2+ was blocked by the angiotensin II receptor AT1 specific antagonist SK&F 108566. This indicates that the rise in Ca2+ is fully mediated by AT1 receptors. To characterize further the antagonism by SK&F 108566, the Schild analysis was performed (pA2 = 10.9 +/- 0.14 and slope = 0.94 +/- 0.11; n=3). It indicated that SK&F 108566 is a high affinity competitive antagonist at AT1 receptors in the proximal tubule. Angiotensin II signaling also induced a rapid (5 min) rise in cGMP formation. This response was blocked by SK&F 108566, by inhibition of nitric oxide synthase, or by inhibition of soluble guanylyl cyclase. This indicates that the formation of cGMP elicited by angiotensin II is mediated by AT1 receptors and activation of the NO-cGMP pathway. Since cGMP can inhibit Na, K-ATPase activity, activation of the NO-cGMP pathway may act as a negative feedback component of angiotensin II signaling in renal proximal tubules. Topics: Acrylates; Angiotensin II; Animals; Antihypertensive Agents; Calcium; Cyclic GMP; Imidazoles; Kidney Tubules, Proximal; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiophenes | 1998 |